168 related articles for article (PubMed ID: 27587361)
1. Anti-GP2 IgA: a biomarker for disease severity and/or cholangiocarcinoma in primary sclerosing cholangitis?
Rizvi S; Yang JD; Gores GJ
Gut; 2017 Jan; 66(1):4-5. PubMed ID: 27587361
[No Abstract] [Full Text] [Related]
2. Anti-GP2 IgA autoantibodies are associated with poor survival and cholangiocarcinoma in primary sclerosing cholangitis.
Jendrek ST; Gotthardt D; Nitzsche T; Widmann L; Korf T; Michaels MA; Weiss KH; Liaskou E; Vesterhus M; Karlsen TH; Mindorf S; Schemmer P; Bär F; Teegen B; Schröder T; Ehlers M; Hammers CM; Komorowski L; Lehnert H; Fellermann K; Derer S; Hov JR; Sina C
Gut; 2017 Jan; 66(1):137-144. PubMed ID: 27406039
[TBL] [Abstract][Full Text] [Related]
3. Anti-glycoprotein 2 (anti-GP2) IgA and anti-neutrophil cytoplasmic antibodies to serine proteinase 3 (PR3-ANCA): antibodies to predict severe disease, poor survival and cholangiocarcinoma in primary sclerosing cholangitis.
Wunsch E; Norman GL; Milkiewicz M; Krawczyk M; Bentow C; Shums Z; Mahler M; Lopens S; Reinhold D; Franke A; Schramm C; Roggenbuck D; Milkiewicz P
Aliment Pharmacol Ther; 2021 Jan; 53(2):302-313. PubMed ID: 33159471
[TBL] [Abstract][Full Text] [Related]
4. Expression of p53 and PCNA in cholangiocarcinoma and primary sclerosing cholangitis.
Batheja N; Suriawinata A; Saxena R; Ionescu G; Schwartz M; Thung SN
Mod Pathol; 2000 Dec; 13(12):1265-8. PubMed ID: 11144921
[TBL] [Abstract][Full Text] [Related]
5. Immunoglobulin G4-related sclerosing cholangitis mimicking hilar cholangiocarcinoma diagnosed with following bile duct resection: report of a case.
Miki A; Sakuma Y; Ohzawa H; Sanada Y; Sasanuma H; Lefor AT; Sata N; Yasuda Y
Int Surg; 2015 Mar; 100(3):480-5. PubMed ID: 25785331
[TBL] [Abstract][Full Text] [Related]
6. A localized primary sclerosing cholangitis preoperatively diagnosed as hilar cholangiocarcinoma; report of a case.
Kojima T; Shimura T; Takahashi M; Haga N; Hashimoto S; Fukuda T; Kuwano H
Hepatogastroenterology; 2004; 51(58):961-3. PubMed ID: 15239224
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis and management of cholangiocarcinoma in primary sclerosing cholangitis.
Ahrendt SA; Pitt HA; Nakeeb A; Klein AS; Lillemoe KD; Kalloo AN; Cameron JL
J Gastrointest Surg; 1999; 3(4):357-67; discussion 367-8. PubMed ID: 10482687
[TBL] [Abstract][Full Text] [Related]
8. Superficial thrombophlebitis, dysplasia, and cholangiocarcinoma in primary sclerosing cholangitis.
Martins EB; Fleming KA; Garrido MC; Hine KR; Chapman RW
Gastroenterology; 1994 Aug; 107(2):537-42. PubMed ID: 8039630
[TBL] [Abstract][Full Text] [Related]
9. An animal model of benign bile-duct stricture, sclerosing cholangitis and cholangiocarcinoma and the role of epidermal growth factor receptor in ductal proliferation.
Cheifetz RE; Davis NL; Owen DA
Can J Surg; 1996 Jun; 39(3):193-7. PubMed ID: 8640617
[TBL] [Abstract][Full Text] [Related]
10. Intrahepatic segmental primary sclerosing cholangitis: report of a case.
Matsumoto T; Ajiki T; Matsumoto I; Tominaga M; Hori H; Mita Y; Fujita T; Fujino Y; Suzuki Y; Ku Y; Kuroda Y
Surg Today; 2006; 36(7):638-41. PubMed ID: 16794801
[TBL] [Abstract][Full Text] [Related]
11. A case of intrahepatic cholangiocarcinoma associated with primary sclerosing cholangitis.
Kanemitsu E; Esaki M
Jpn J Clin Oncol; 2010 Jun; 40(6):600. PubMed ID: 20508074
[No Abstract] [Full Text] [Related]
12. The Changing Face of the Diagnosis of Chronic and Malignant Liver Diseases: Potential New Biomarkers.
Cruz-Ramón V; Chinchilla-López P; Ramírez-Pérez O; Qi X; Méndez-Sánchez N
Ann Hepatol; 2018; 17(1):14-17. PubMed ID: 29311406
[TBL] [Abstract][Full Text] [Related]
13. Diagnosing cholangiocarcinoma in primary sclerosing cholangitis: an "evidence based radiology" review.
Walker SL; McCormick PA
Abdom Imaging; 2008; 33(1):14-7. PubMed ID: 17874262
[TBL] [Abstract][Full Text] [Related]
14. Editorial: serologic antibodies in primary sclerosing cholangitis-a tell-tale sign of compromised gut-liver immunity? Authors' reply.
Wunsch E; Milkiewicz P
Aliment Pharmacol Ther; 2021 Jan; 53(2):352-353. PubMed ID: 33368503
[No Abstract] [Full Text] [Related]
15. Cholangiocarcinoma associated with hypercalcaemia and ascites presenting as sclerosing cholangitis.
D'Costa DF
Br J Clin Pract; 1994; 48(4):217-8. PubMed ID: 7917805
[TBL] [Abstract][Full Text] [Related]
16. Cholangioscopy to screen for cholangiocarcinoma in primary sclerosing cholangitis.
Caldwell SH; Bickston SJ
Liver Transpl; 2001 Apr; 7(4):380. PubMed ID: 11303302
[No Abstract] [Full Text] [Related]
17. Clinical clues to suspicion of IgG4-associated sclerosing cholangitis disguised as primary sclerosing cholangitis or hilar cholangiocarcinoma.
Oh HC; Kim MH; Lee KT; Lee JK; Moon SH; Song TJ; Eum J; Park DH; Lee SS; Seo DW; Lee SK
J Gastroenterol Hepatol; 2010 Dec; 25(12):1831-7. PubMed ID: 21091993
[TBL] [Abstract][Full Text] [Related]
18. MR Imaging in Primary Sclerosing Cholangitis and Other Cholangitis.
O'Brien C; Malik M; Jhaveri K
Radiol Clin North Am; 2022 Sep; 60(5):843-856. PubMed ID: 35989048
[TBL] [Abstract][Full Text] [Related]
19. Immunoglobulin G4-related lymphoplasmacytic sclerosing cholangitis that mimics infiltrating hilar cholangiocarcinoma: part of a spectrum of autoimmune pancreatitis?
Hamano H; Kawa S; Uehara T; Ochi Y; Takayama M; Komatsu K; Muraki T; Umino J; Kiyosawa K; Miyagawa S
Gastrointest Endosc; 2005 Jul; 62(1):152-7. PubMed ID: 15990840
[TBL] [Abstract][Full Text] [Related]
20. Recent developments in the research on biomarkers of cholangiocarcinoma in primary sclerosing cholangitis.
Wannhoff A; Gotthardt DN
Clin Res Hepatol Gastroenterol; 2019 Jun; 43(3):236-243. PubMed ID: 30266579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
